BioSpace News Archive

Business

Amgen Announces Succession Plans For Two Executive Officers

As part of Amgen’s planned executive succession to address upcoming retirements, the Company announced transition plans for two of its executive vice presidents today.

July 26, 2018
·
9 min read
Business

Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018

Expects Revenue Growth of at Least 20% for Fiscal Year 2019

July 26, 2018
·
18 min read
Business

Planet Fitness, Inc. to Report Second Quarter 2018 Results on August 9, 2018

Planet Fitness, Inc. announced that the Company will report results for its second quarter ended June 30, 2018 after the market closes on Thursday, August 9, 2018.

July 26, 2018
·
1 min read
Policy

Statement - CMA’s call to action opens the door for federal government to support much-needed United Nations Convention on the Rights of Older Persons

The Canadian Medical Association (CMA) has been pursuing improved health care and quality of life for our aging population for the past five years.

July 26, 2018
·
1 min read
Policy

RM LAW Announces Class Action Lawsuit Against ACADIA Pharmaceuticals Inc.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased ACADIA Pharmaceuticals Inc.

July 26, 2018
·
4 min read
Biotech Beach

Halozyme Therapeutics To Participate In Upcoming Healthcare Conference

Halozyme Therapeutics, Inc. will be presenting at the Canaccord Genuity 38th Annual Growth Conference in Boston on Thursday, August 9 at 12:00 p.m. ET/9:00 a.m. PT.

July 26, 2018
·
1 min read
Drug Development

Principia Confirms Human CNS Exposure and Good Tolerability of Oral BTK Inhibitor PRN2246

Principia Biopharma Inc. today announced that dosing has been completed for all participants in a Phase 1 clinical trial of PRN2246, a Bruton’s tyrosine kinase (BTK) inhibitor designed to cross the human blood-brain barrier.

July 26, 2018
·
2 min read
Business

Edwards Lifesciences Reports 2018 Second Quarter Results

Edwards Lifesciences Corporation reported financial results for the quarter ended June 30, 2018.

July 26, 2018
·
47 min read
Business

Orthofix Schedules Second Quarter 2018 Earnings Release and Conference Call for August 6, 2018

Orthofix International N.V. announced that it plans to release financial results for the second quarter 2018 after market close on Monday, August 6, 2018.

July 26, 2018
·
1 min read
Drug Development

CBT Pharmaceuticals Initiates Phase 1b Clinical Trial for Anti-PD-1 Antibody CBT-501-01 (genolimzumab injection) in Patients with Advanced Solid Tumors

CBT Pharmaceuticals today announced the continuation of the CBT-501 Phase 1 clinical trial with the initiation of the Phase 1b segment of the study in patients with select advanced or relapsed/recurrent solid tumors.

July 26, 2018
·
2 min read